Question
Is fluvoxamine effective in preventing hospitalizations in high-risk adults with COVID-19?
Conclusion
In this study, compared with placebo, fluvoxamine decreased hospitalizations in high-risk symptomatic adults with COVID-19.
Recent Posts
- How do ibuprofen, ketorolac, and diclofenac compare for the treatment of acute, nonradicular low back pain in adults?
- Are platelet-rich plasma injections effective for alleviating pain and improving function in adults with symptomatic ankle osteoarthritis?
- Recurrent herpes zoster more common in women, younger adults, and the immunosuppressed
- Evidence of benefit is lacking for low back pain relief with muscle relaxants
- Fluvoxamine decreases hospitalizations in high-risk adults with COVID-19 (TOGETHER)